Resultados de búsqueda - Sha Cheng
- Mostrando 1 - 3 Resultados de 3
-
1
Correction: Lin et al. Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 Targets. <i>Pharmaceuticals</i> 2025, <i>18</i>, 428 por Dengxiao Lin, Wenfeng Yu, Jia Yu, Sha Cheng, Yu Song, Xiaoqing Wan, Yingjiang Xu, Heng Luo, Baofei Sun
Publicado 2025-05-01In the original publication [...]
Enlace del recurso
Artículo -
2
Relationship between peripheral blood miR-146b-5p levels and lymphocyte subsets in patients with sepsis and its predictive value for prognosis: a single-center study por Sha Cheng, Jiaojiao Wang, Pengfei Wang, Xianli Long, Huiling Liu, Xueyin Li, Xiaowei Zhang, Xuemei Zhao, Hang Sun, Chuanxin Wu
Publicado 2025-06-01BackgroundSepsis is a life-threatening disease with challenges in clinical management due to delayed diagnosis and immunosuppression. Lymphopenia is a key prognostic indicator in sepsis. microRNAs (miRNAs) are recognized as key immune modulators affecting all stages of inflammation. In this study, w...
Enlace del recurso
Artículo -
3
Orphan Class A GPCRs Signature Predicts Prognosis and Immune Microenvironment in Gastric Cancer: GPR176 Drives Tumor Progression Through Wnt Signaling and Macrophage Polarization por Jiahui Lin, Lingling Ke, Sha Cheng, Wei Lu, Yanan Hu, Xiyi He, Tingting Luo, Yuting Liu, Canxia Xu, Jian Qi
Publicado 2025-01-01Conclusion: These findings may provide new insights into the role of orphan class A GPR genes in STAD and identify GPR176 as a new therapeutic target for GC.
Enlace del recurso
Artículo